Evidence map›Paper›PMID 37514057›Full record

ArticlePharmaceutics2023

Azizbek D Usvaliev, Natalia G Belogurova, Konstantin V Pokholok, Alexander V Finko, Andrey N Prusov, Dmitry Yu Golovin, Konstantin A Miroshnikov, Yuri I Golovin, Natalia L Klyachko

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Azizbek D UsvalievSchool of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia.
Natalia G BelogurovaSchool of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia.
Konstantin V PokholokSchool of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia.
Alexander V FinkoSchool of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia.ORCID 0000-0002-1334-9485
Andrey N PrusovA.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia.
Dmitry Yu GolovinInstitute of Nanomaterials and Nanotechnologies, G.R. Derzhavin Tambov State University, Tambov 392000, Russia.
Konstantin A MiroshnikovShemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia.ORCID 0000-0002-4468-4091
Yuri I GolovinSchool of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia.
Natalia L KlyachkoSchool of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia.ORCID 0000-0002-9357-8236
Lomonosov Moscow State University · RUTambov State University · RUInstitute of Bioorganic Chemistry · RUSkolkovo Institute of Science and Technology · RU

Funding

Lomonosov Moscow State University AAAA-A21-121011290089-4Russian Science Foundation 22-13-00261
6 · The paper itself

Abstract

The spreading of microbial pathogens with more and more resistance to traditional low-molecular antibiotic agents demands new approaches to antibacterial therapy. The employment of bacteriophage enzymes capable of breaking bacterial cell walls has attracted much interest within this context. The specific features of the morphology of Gram-negative bacteria prevent the effective direct usage of lytic enzymes and require assistance from additional helpers to facilitate cell lysis. The current work is devoted to the study of boosting the lysis of

Indexed as

E. coli cell wallenzymatic lysis of Gram-negative bacterianon-heating low-frequency magnetic fieldrod-like magnetic nanoparticlesS-394 bacteriophage endolysin

Identifiers

PMID37514057
PMCPMC10384812
OpenAlexW4382936543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.